Novel Therapeutic Targets in Melanoma.
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
25 Jan 2023
25 Jan 2023
Historique:
received:
23
12
2022
accepted:
17
01
2023
entrez:
11
2
2023
pubmed:
12
2
2023
medline:
12
2
2023
Statut:
epublish
Résumé
Melanoma is the most aggressive skin cancer type and ranks amongst the deadliest cancers due to its ability to develop resistance to current therapies [...].
Identifiants
pubmed: 36765705
pii: cancers15030747
doi: 10.3390/cancers15030747
pmc: PMC9913784
pii:
doi:
Types de publication
Editorial
Langues
eng
Références
Cancers (Basel). 2022 Jul 11;14(14):
pubmed: 35884430
Cancers (Basel). 2022 Jan 06;14(2):
pubmed: 35053435
Cancers (Basel). 2021 Nov 03;13(21):
pubmed: 34771678
Cancers (Basel). 2021 Nov 27;13(23):
pubmed: 34885078
Cancers (Basel). 2022 Jan 29;14(3):
pubmed: 35158973
Cancers (Basel). 2022 Apr 23;14(9):
pubmed: 35565234
Cancers (Basel). 2021 Dec 08;13(24):
pubmed: 34944799
Cancers (Basel). 2021 Jul 15;13(14):
pubmed: 34298765
Cancers (Basel). 2021 Dec 07;13(24):
pubmed: 34944771
Cancers (Basel). 2022 May 16;14(10):
pubmed: 35626062